{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:13:28Z","timestamp":1783970008789,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"U.S. Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["6 U01IP001048-04-02"],"award-info":[{"award-number":["6 U01IP001048-04-02"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221003\/Z\/20\/Z"],"award-info":[{"award-number":["221003\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Data on the characteristics of individuals with mild and asymptomatic infections with different SARS-CoV-2 variants are limited. We therefore compared the characteristics of individuals infected with ancestral, Beta and Delta SARS-CoV-2 variants in South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study in a rural and an urban site during July 2020-August 2021. Mid-turbinate nasal swabs were collected twice-weekly from household members irrespective of symptoms and tested for SARS-CoV-2 using real-time reverse transcription polymerase chain reaction (rRT-PCR). Differences in demographic and clinical characteristics, shedding and cycle threshold (Ct) value of infection episodes by variant were evaluated using multinomial regression. Overall and age-specific incidence rates of infection were compared by variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 1200 individuals from 222 households and 648 rRT-PCR-confirmed infection episodes (66, 10%\u00a0ancestral, 260, 40% Beta, 322, 50%\u00a0Delta). Symptomatic proportion was similar for ancestral (7, 11%), Beta (44, 17%), and Delta (46, 14%) infections (\n                      <jats:italic>p<\/jats:italic>\n                      =0.4). After accounting for previous infection, peak incidence shifted to younger age groups in successive waves (40-59 years ancestral, 19-39 years Beta, 13-18 years Delta). On multivariable analysis, compared to ancestral, Beta infection was more common in individuals aged 5-12 years (vs 19-39)(adjusted odds ratio (aOR) 2.6, 95% confidence interval (CI)1.1-6.6) and PCR cycle threshold (Ct) value &lt;30 (vs &gt;35)(aOR 3.2, 95%CI 1.3-7.9), while Delta was more common in individuals aged &lt;5 (aOR 6.7, 95%CI1.4-31.2) and 5-12 years (aOR 6.6 95%CI2.6-16.7)(vs 19-39) and Ct value &lt;30 (aOR 4.5, 95%CI 1.3-15.5) and 30-35 (aOR 6.0, 95%CI 2.3-15.7)(vs &gt;35).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Consecutive SARS-CoV-2 waves with Beta and Delta variants were associated with a shift to younger individuals. Beta and Delta infections were associated with higher peak viral loads, potentially increasing infectiousness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09209-z","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:02:30Z","timestamp":1711004550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021"],"prefix":"10.1186","volume":"24","author":[{"given":"Cheryl","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Kleynhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith L.","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinal N.","family":"Bhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Moyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimuna","family":"Carrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limakatso","family":"Lebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floidy","family":"Wafawanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc Xavier","family":"G\u00f3mez-Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah S.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thulisa","family":"Mkhencele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PHIRST group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tempia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"9209_CR1","doi-asserted-by":"publisher","unstructured":"Mahilkar S et al. SARS-CoV-2 variants: Impact on biological and clinical outcome. Front Med (Lausanne). 2022;9:995960. https:\/\/doi.org\/10.3389\/fmed.2022.995960.","DOI":"10.3389\/fmed.2022.995960"},{"key":"9209_CR2","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41591-022-01836-w","volume":"28","author":"L Subissi","year":"2022","unstructured":"Subissi L, et al. An early warning system for emerging SARS-CoV-2 variants. Nat Med. 2022;28:1110\u20135.","journal-title":"Nat Med"},{"key":"9209_CR3","doi-asserted-by":"publisher","first-page":"e1216","DOI":"10.1016\/S2214-109X(21)00289-8","volume":"9","author":"W Jassat","year":"2021","unstructured":"Jassat W, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Heal. 2021;9:e1216\u201325.","journal-title":"Lancet Glob Heal"},{"key":"9209_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40121-020-00324-3","volume":"9","author":"SN Rao","year":"2020","unstructured":"Rao SN, Manissero D, Steele VR, Pareja J. A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19. Infect Dis Ther. 2020;9:573\u201386.","journal-title":"Infect Dis Ther"},{"key":"9209_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12881","author":"C Cohen","year":"2021","unstructured":"Cohen C, et al. Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016\u20132018 Influenza Other Respi. Viruses. 2021. https:\/\/doi.org\/10.1111\/irv.12881.","journal-title":"Viruses"},{"key":"9209_CR6","doi-asserted-by":"publisher","unstructured":"Cohen C, Kleynhans J, Moyes J, McMorrow ML, Treurnicht FK. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017\u201318 (PHIRST): a population cohort study. Lancet Glob Health. 2021;9(6):e863\u201374. https:\/\/doi.org\/10.1016\/S2214-109X(21)00141-8.","DOI":"10.1016\/S2214-109X(21)00141-8"},{"key":"9209_CR7","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3201\/eid2712.211465","volume":"27","author":"J Kleynhans","year":"2021","unstructured":"Kleynhans J, et al. SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020-March 2021. Emerg Infect Dis. 2021;27(12):3020\u20139. https:\/\/doi.org\/10.3201\/eid2712.211465.","journal-title":"Emerg Infect Dis"},{"key":"9209_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1473-3099(22)00069-X","volume":"22","author":"C Cohen","year":"2022","unstructured":"Cohen C, et al. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020\u201321. Lancet Infect Dis. 2022;22:821\u201334.","journal-title":"Lancet Infect Dis"},{"key":"9209_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ije\/dys115","volume":"41","author":"K Kahn","year":"2012","unstructured":"Kahn K, et al. Profile: agincourt health and socio-demographic surveillance system. Int J Epidemiol. 2012;41:988\u20131001.","journal-title":"Int J Epidemiol"},{"key":"9209_CR10","doi-asserted-by":"publisher","first-page":"32795","DOI":"10.3402\/gha.v9.32795","volume":"9","author":"M Garenne","year":"2016","unstructured":"Garenne M, et al. Completeness of birth and death registration in a rural area of South Africa: the Agincourt health and demographic surveillance, 1992\u20132014. Glob Health Action. 2016;9:32795.","journal-title":"Glob Health Action"},{"key":"9209_CR11","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"9209_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12879-021-05950-x","volume":"21","author":"M Alene","year":"2021","unstructured":"Alene M, et al. Serial interval and incubation period of COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:257.","journal-title":"BMC Infect Dis"},{"key":"9209_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.15585\/mmwr.mm7036e1","volume":"70","author":"DA Siegel","year":"2021","unstructured":"Siegel DA, et al. Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0\u201317 years - United States, August 2020-August 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1249\u201354.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9209_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12889-022-14906-y","volume":"23","author":"TA Rotevatn","year":"2023","unstructured":"Rotevatn TA, et al. When schools were open for in-person teaching during the COVID-19 pandemic - the nordic experience on control measures and transmission in schools during the delta wave. BMC Public Health. 2023;23:62.","journal-title":"BMC Public Health"},{"key":"9209_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piad002","author":"N Chiwandire","year":"2023","unstructured":"Chiwandire N, et al. Changing epidemiology of COVID-19 in children and adolescents over four successive epidemic waves in South Africa, 2020\u20132022. J Pediatric Infect Dis Soc. 2023. https:\/\/doi.org\/10.1093\/jpids\/piad002.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"9209_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/irv.12949","volume":"16","author":"S Tempia","year":"2022","unstructured":"Tempia S, et al. The national burden of influenza-like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013\u20132015. Influenza Other Respi Viruses. 2022;16:438\u201351.","journal-title":"Influenza Other Respi Viruses"},{"key":"9209_CR17","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41591-022-01816-0","volume":"28","author":"O Puhach","year":"2022","unstructured":"Puhach O, et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022;28:1491\u2013500.","journal-title":"Nat Med"},{"key":"9209_CR18","doi-asserted-by":"publisher","unstructured":"Kawasuji H, et al. Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients. PLoS One. 2020;15(12):e0243597. https:\/\/doi.org\/10.1371\/journal.pone.0243597. eCollection 2020.","DOI":"10.1371\/journal.pone.0243597"},{"key":"9209_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:672\u20135.","journal-title":"Nat Med"},{"key":"9209_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","volume":"22","author":"A Singanayagam","year":"2022","unstructured":"Singanayagam A, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22:183\u201395.","journal-title":"Lancet Infect Dis."},{"key":"9209_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1473-3099(22)00141-4","volume":"22","author":"A Sheikh","year":"2022","unstructured":"Sheikh A, et al. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design. Lancet Infect Dis. 2022;22:959\u201366.","journal-title":"Lancet Infect Dis"},{"key":"9209_CR22","doi-asserted-by":"publisher","first-page":"e1003346","DOI":"10.1371\/journal.pmed.1003346","volume":"17","author":"D Buitrago-Garcia","year":"2020","unstructured":"Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346.","journal-title":"PLoS Med"},{"key":"9209_CR23","doi-asserted-by":"publisher","unstructured":"Awandu SS, et al. High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya. PLoS One. 2022;17(12):e0272751. https:\/\/doi.org\/10.1371\/journal.pone.0272751. eCollection 2022.","DOI":"10.1371\/journal.pone.0272751"},{"key":"9209_CR24","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1093\/cid\/ciac640","volume":"76","author":"J Kleynhans","year":"2023","unstructured":"Kleynhans J, et al. Household transmission of severe acute respiratory syndrome coronavirus 2 from adult index cases with and without human immunodeficiency virus in South Africa, 2020\u20132021: a case-ascertained, prospective, observational household transmission study. Clin Infect Dis. 2023;76:E71\u201381.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09209-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:02:57Z","timestamp":1711004577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09209-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9209"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09209-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3452480\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PHIRST protocol was reviewed and approved by the University of Witwatersrand Human Research Ethics Committee (Reference 150808) and amended to include enrolment and testing for COVID-19 on 24 June 2020. The study was registered on clinicaltrials.gov, registration number NCT02519803 11\/08\/2015 (\n                      \n                      ). Participants received grocery store vouchers of USD 3 per visit to compensate for the time required for specimen collection and interview. All participants provided informed consent. For minors informed consent was obtained from a parent or legal guardian.The full study protocol including informed consent forms can be found on the NICD website at the following link:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CC has received grant support from Sanofi Pasteur, US CDC, Welcome Trust, Programme for Applied Technologies in Health (PATH), Bill & Melinda Gates Foundation and South African Medical Research Council (SA-MRC). AvG has received grant support from CDC, ASLM\/Africa CDC, SA-MRC, WHO Afro, Fleming Fund, WHO, Wellcome Trust . NW reports grants from Sanofi Pasteur and the Bill & Melinda Gates Foundation. NAM has received a grant to his institution from Pfizer to conduct research in patients with pneumonia and from Roche to collect specimens to assess a novel TB assay. JM has received grant support from Sanofi Pasteur and PATH. JB has received grant funds from EDCTP, Fleming Fund, SAMRC. Other authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}